全文获取类型
收费全文 | 4541篇 |
免费 | 279篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 76篇 |
儿科学 | 155篇 |
妇产科学 | 63篇 |
基础医学 | 507篇 |
口腔科学 | 316篇 |
临床医学 | 259篇 |
内科学 | 1327篇 |
皮肤病学 | 100篇 |
神经病学 | 287篇 |
特种医学 | 101篇 |
外科学 | 664篇 |
综合类 | 15篇 |
一般理论 | 1篇 |
预防医学 | 288篇 |
眼科学 | 59篇 |
药学 | 285篇 |
中国医学 | 10篇 |
肿瘤学 | 315篇 |
出版年
2023年 | 22篇 |
2022年 | 49篇 |
2021年 | 156篇 |
2020年 | 72篇 |
2019年 | 127篇 |
2018年 | 156篇 |
2017年 | 110篇 |
2016年 | 98篇 |
2015年 | 120篇 |
2014年 | 150篇 |
2013年 | 184篇 |
2012年 | 256篇 |
2011年 | 292篇 |
2010年 | 167篇 |
2009年 | 182篇 |
2008年 | 219篇 |
2007年 | 262篇 |
2006年 | 214篇 |
2005年 | 242篇 |
2004年 | 237篇 |
2003年 | 210篇 |
2002年 | 198篇 |
2001年 | 152篇 |
2000年 | 193篇 |
1999年 | 129篇 |
1998年 | 49篇 |
1997年 | 40篇 |
1996年 | 34篇 |
1995年 | 18篇 |
1994年 | 21篇 |
1993年 | 14篇 |
1992年 | 71篇 |
1991年 | 63篇 |
1990年 | 62篇 |
1989年 | 48篇 |
1988年 | 37篇 |
1987年 | 26篇 |
1986年 | 24篇 |
1985年 | 20篇 |
1984年 | 7篇 |
1983年 | 10篇 |
1979年 | 10篇 |
1978年 | 7篇 |
1975年 | 8篇 |
1974年 | 5篇 |
1972年 | 4篇 |
1971年 | 4篇 |
1970年 | 7篇 |
1968年 | 7篇 |
1966年 | 4篇 |
排序方式: 共有4828条查询结果,搜索用时 0 毫秒
71.
Matos S Guerra F Krauser JT Figueiredo H Marcelino JP Sanz M 《Clinical oral implants research》2012,23(6):698-705
Objectives: The present investigation aimed to assess the bone‐regenerative potential of two formulations of anorganic bovine‐derived mineral bound to a P‐15 (ABM/P‐15) bone graft – the particulate and the hydrogel forms – in a delayed healing rabbit cranial defect model. Material and methods: Ten adult male New Zealand White rabbits were used to create two 8 mm transcortical cranial defects per rabbit and each one received randomly the test material (ABM/P‐15 carboxymethyl cellulose (CMC)‐hydrogel graft), the standard control material (ABM/P‐15 particulate graft) or remained empty as a negative control. The defects were allowed to heal for 2 and 4 weeks. Qualitative and quantitative histological outcomes were assessed on undecalcified sections. Results: In the defects grafted with the test material, at both time points, there was a marked random migration of the bone substitute particles. As a consequence, the space maintenance provision was lost and new bone formation was reduced compared with the control particulate graft material. The histomorphometric analysis showed that the control material attained better results, with an average of 13.8 ± 1.9% and 18.2 ± 4.4% of new bone at 2 and 4 weeks, compared with 8.5 ± 2.4% and 13 ± 2.9% for the test material. These differences were significant at 2 weeks (P≤0.05), but not at 4 weeks (P>0.05). Additionally, there was a significant difference in the total area of mineralized tissue (new bone plus particles), favoring the standard control over the test material: 43.2 ± 14.4% vs. 14.2 ± 5.3% at 2 weeks and 56.9 ± 4.2% vs. 24.2 ± 9.6% at 4 weeks, respectively. Conclusions: The test ABM/P‐15 CMC‐hydrogel graft material behaved in this animal model by migration of the graft particles, what determined an unpredictable osseoconduction and, consequently, a decreased quality and quantity of bone regeneration as compared with the osseopromotive behavior exhibited by the standard particulate form of the ABM/P‐15 control graft. It is therefore suggested to restrain the application of the hydrogel graft form in non‐contained anatomical bone defects. 相似文献
72.
73.
74.
75.
76.
77.
The outcome of community-acquired pneumonia (CAP) depends on the interaction between the infectious agent and the host response. Nowadays the etiology of CAP can be established in ~60% of the cases, and Streptococcus pneumoniae remains the main etiological agent in outpatients, those hospitalized, or those requiring intensive care unit (ICU) admission. Recently, the development of nucleic acid amplification techniques has emphasized the role of viruses as important etiological agents in CAP. However, some demographic factors and comorbidities will determine a higher risk of pneumonia. Thus elderly patients or those with toxic habits (smoking, alcohol abuse), and the presence of various comorbidities (respiratory, metabolic, or renal) favor the development of pneumonia by altering the inflammatory response to infection.Some medications like inhaled corticosteroids could play a role in CAP development in chronic obstructive pulmonary disease (COPD) patients. Fortunately some of these risk factors are preventable and modifiable, for example, through smoking cessation and pneumococcal and influenza vaccinations, which are the biggest successes. 相似文献
78.
79.
Podzamczer D Tiraboschi JM Mallolas J Curto J Cardenes MA Casas E Castro A Echevarria S Leal M de Quiros JC Moreno S Puig T Ribera E Villalonga C Gomez-Sirvent JL Garcia-Henarejos JA Lopez-Aldeguer J Barrufet P Force L Santos I Sanz J 《Current HIV research》2012,10(6):513-520
Objective: To evaluate long-term outcomes in patients maintaining a nevirapine (NVP)-based regimen. Methods: Retrospective, multicenter, cohort study including patients currently receiving an NVP regimen that had been started at least 5 years previously. Demographic, clinical, and analytical variables were recorded. Results: Median follow-up was 8.9 (5.7-11.3) years. Baseline characteristics: 74% men, 47 years old, 36% drug users, 40% AIDS, 40% HCV+, 51.4% detectable HIV-1 viral load, CD4 count 395 (4-1,421)/μL, 19% CD4 < 200/μL, 27% ALT grade 1-2, 36% AST grade 1-2. Thirty percent ART-naive, 83%received NVP associated with 2 nucleoside analogues during the study period, and 17% a protease inhibitor. A significant improvement was observed in general health status markers, including hemoglobin, platelets, and albumin, regardless of HCV coinfection. CD4 cell gain was +218 and +322/μL after 6 and 9 years, respectively (+321 and +391 in naive patients). Triglycerides significantly decreased in pretreated patients, whereas the percentage of patients with HDLc < 1.03 mmol/L and LDL-c > 3.37 mmol/L significantly decreased in a subsample with available values. A significant decrease in transaminases, alkaline phosphatase, and Fib4 score was observed, mainly in HCV+ and ARV-naive patients. Conclusions: In patients who tolerate NVP therapy, (even those with HCV coinfection), long term benefits may be significant in terms of a progressive improvement in general health status markers and CD4 response, a favorable lipid profile, and good liver tolerability. 相似文献